Biolocity

Breakthrough discoveries deserve a pathway to impact. That's why we're excited to celebrate the success of the inaugural Biolocity Pitch Competition—an opportunity for Georgia Institute of Technology and Emory University innovators to receive candid feedback from experienced investors, entrepreneurs, and commercialization experts as they work to transform breakthrough discoveries into real-world healthcare solutions. Congratulations to Logicyte, recipient of the inaugural $10,000 Biolocity Pitch Competition Award! Led by Norh Asmare, PhD, Co-Founder and CEO, Logicyte is developing technology to enable fully autonomous cell therapy manufacturing—an innovation with the potential to improve the consistency, efficiency, and scalability of regenerative medicine. While Logicyte received this year's award, every participating team contributed to the competition's success. The thoughtful discussions, strategic feedback, and meaningful connections created during the event will continue to help these innovators strengthen their commercialization strategies and move their technologies closer to patient impact. A sincere thank you to our outstanding panel of judges for sharing their expertise and investing in the future of biomedical innovation: Nettie Brown, PhD Ambika Bumb Albert K. Chin, M.D. Miguel Lacayo Jeffrey Lawson Preetha Ram Michael Tanenbaum Alexander Vo This competition reflects Biolocity's mission to bridge the gap between discovery and impact by providing innovators with the funding, education, mentorship, and strategic connections they need to successfully commercialize breakthrough biomedical technologies. 📖 Read the full announcement here: https://lnkd.in/gnvWShnY #Biolocity #GeorgiaTech #Emory #HealthcareInnovation #MedTech #LifeSciences #Commercialization #Entrepreneurship #BiomedicalInnovation #Startup #InnovationEcosystem The The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University Emory University Emory University School of Medicine Angela Gill Nelms Jessie Buckelew

We will kickoff these teams on August 1. Make sure you follow us to hear more about their progress throughout the year in this highly intensive program!!

Biolocity is proud to announce the awardees for the 2026–2027 program cycle, recognizing promising innovations in biotechnology, medical devices, diagnostics, therapeutics, and digital health. Selected from Georgia Tech and Emory University, these teams represent high-potential technologies poised to advance healthcare and improve patient outcomes. Through a competitive, multi-stage evaluation process, Biolocity identifies and supports technologies with strong commercialization potential. In addition to funding, teams receive intensive support in areas such as commercialization strategy, milestone development, market assessment, and pitch preparation, working alongside experienced entrepreneur advisors to accelerate progress, reduce risk, and strengthen readiness for downstream funding and market adoption. Final cohort selection is made by Biolocity’s Oversight Committee, a multidisciplinary panel of investors, entrepreneurs, clinicians, engineers, and technology transfer leaders who evaluate each opportunity for innovation, impact, execution readiness, and commercial potential. The 2026–2027 program will include both a full Biolocity Cohort and a Seed Funding Group. Full cohort teams will participate in Biolocity’s intensive commercialization programming through biweekly milestone-focused meetings centered on strategic development, execution, and investor readiness. Seed-funded teams will participate in quarterly commercialization and milestone review meetings designed to support promising early-stage technologies as they continue to mature. This Year’s Full Cohort Features: CELORB Team Members: Shuichi Takayama, PhD; Yesim Gokmen-Polar, PhD; Nathan Rojas Ocampo OrganoAb Biosciences Team Members: Ankur Singh, PhD; Andres Garcia, PhD; Tracey Mullen, MBA; Jean Koff, MD, MS Protected Surgical Suction Tip Principal Investigator: Orr Shauly, MD This Year’s Seed Funding Group Features: AnchorDoc Team Members: Yue Chen, PhD; Samuel Wilcox; Chang Zhou, PhD; John Moon, MD; Hanssen Li, MD; Nick Lima, MD Blood Rheology Solutions Team Members: Vivien Sheehan, MD, PhD; Wilbur A. Lam, MD, PhD; Ashwin Patel, MBBS, PhD, MPH, Megan Merritt-Garza, MS; Srija Ponna, MS; Jedidah Titus, BS EsoBASE™ Team Members: Anand Jain, MD NeuroBot Team Members: Kimberly Hoang MD MBA FAANS; Azadeh Ansari, PhD; Emmett Freeman WorkforceIQ Team Members: Omid Razmpour, PhD, MBA, RN; Sokol Tushe, PhD; Donald Lee, PhD; Tyki Wada, MBA ( Tyki W.) Congratulations to all of the 2026–2027 Biolocity awardees. Alyssa Panitch Angela Gill Nelms Jessie Buckelew The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University Emory University Emory University School of Medicine Georgia Institute of Technology Georgia Tech College of Sciences Georgia Tech College of Engineering Patrick Reynolds Sat Balachander Rebecca S. Sarah Jo Tucker, MS, MBA, PMP Sanjana Singh, MBID Akshay Chander Grace Powers, FRAPS, MS, MBA, RAC Emory Technology Transfer

Building the next great technology at Emory University? Make sure to swing by these office hours!!

Join us tomorrow for our next 𝗕𝗲𝗻𝗰𝗵𝟮𝗠𝗮𝗿𝗸𝗲𝘁 𝗧𝗮𝗹𝗸: 𝗘𝗮𝗿𝗹𝘆-𝗦𝘁𝗮𝗴𝗲 𝗨𝘀𝗮𝗯𝗶𝗹𝗶𝘁𝘆: 𝗥𝗲𝗱𝘂𝗰𝗶𝗻𝗴 𝗥𝗶𝘀𝗸 𝗮𝗻𝗱 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗶𝗻𝗴 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻. This session will explore how integrating human factors and usability engineering early in medical device development can help reduce risk, streamline regulatory pathways, and uncover new opportunities for innovation. Featuring Robert Turner, Managing Director of Usability Works, attendees will gain practical strategies for applying formative usability methods at the concept stage to better understand user needs, avoid costly redesigns, and develop safer, more intuitive technologies. 🗓 𝗠𝗮𝘆 𝟮𝟬, 𝟮𝟬𝟮𝟲 🕛 𝟭𝟮:𝟬𝟬–𝟭:𝟬𝟬 𝗣𝗠 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗛𝗲𝗿𝗲: https://lnkd.in/eupKsZjv #Biolocity #Bench2Market #MedicalInnovation #MedTech #HealthcareInnovation

Join us for a Bench2Market Talk on how early-stage usability and human factors engineering can reduce risk, simplify regulatory pathways, and lead to smarter, safer medical device design. 🎤 Featuring Robert Turner, Managing Director of Usability Works 📅 May 20, 2026 🕛 12:00 -1:00 pm Learn how formative usability methods at the concept stage can uncover real user needs and prevent costly redesigns. 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗧𝗼𝗱𝗮𝘆!  https://lnkd.in/eupKsZjv #Bench2Market #MedTechInnovation #HumanFactors #UsabilityDesign #MedicalDevices #Biolocity #StartupScience

Grateful for Edward Lai, MPH keeping us in the loop. See below for May events in the Atlanta ecosystem! Be a part of the amazing work!!

𝗥𝗲𝗺𝗶𝗻𝗱𝗲𝗿: Join us tomorrow for our next Bench2Market Talk, EVP Strategy and Market Access. Kelly Petrucci, EVP of Market Access Operations and Strategy at PRIA Healthcare, will share insights from more than 20 years of experience helping healthcare innovations navigate payer dynamics, patient access, and commercialization strategy. 🗓 May 6, 2026 ⏰ 12:00–1:00 PM ET 📍 Virtual 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝘁𝗼𝗱𝗮𝘆! https://lnkd.in/eB5TaP8Q

This is an AMAZING opportunity!! You will learn so much. Check it out.

For our next Bench2Market talks, we’re excited to welcome Kelly Petrucci, a healthcare market access leader with over two decades of experience driving strategy across pharmaceuticals, medical devices, biologics, and patient access programs. From leading operations and market strategy at PRIA to serving as CEO of Ascend Access Healthcare, Kelly brings deep expertise in payer dynamics, healthcare policy, and commercial strategy. 📅 𝗠𝗮𝘆 𝟲, 𝟮𝟬𝟮𝟲 ⏰ 𝟭𝟮:𝟬𝟬–𝟭:𝟬𝟬 𝗣𝗠 💻 𝗩𝗶𝗿𝘁𝘂𝗮𝗹 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝘁𝗼𝗱𝗮𝘆! https://lnkd.in/eFUWZ7z4 #Bench2MarketTalks #Biolocity #MarketAccess #HealthcareLeadership #BiomedicalInnovation